Qprotyn achieves viscosity of 18cP for 250mg/mL of Trastuzumab using its HILOPRO® technology.
Upgrading Trastuzumab from IV to Subcutaneous (SubQ) administration may now be possible without expensive, high-volume hyaluronidase...
top of page
News @ Qprotyn
Changing the world, one mAb at a time.
We are always pushing the frontier of technology’s impact in the world of biologics. We feel that modern technology allows easy crossover of ideas across borders and cultures. Our achievements and our knowledge are to be shared with the community and the technology ecosystem.
Search
bottom of page